Which has higher earnings & valuation, BDSX or ITGR?

Integer has higher revenue and earnings than Biodesix. Biodesix is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Biodesix $88.50M 2.36 -$35.26M -$4.06 N/A Integer $1.86B 1.67 $102.81M $4.01 22.78

Is BDSX or ITGR more profitable?

Integer has a net margin of 7.64% compared to Biodesix's net margin of -33.26%. Integer's return on equity of 12.83% beat Biodesix's return on equity. Company Net Margins Return on Equity Return on Assets Biodesix -33.26% -2,101.40% -35.65% Integer 7.64% 12.83% 6.51%

Which has preferable earnings & valuation, ITGR or ELV?

Elevance Health has higher revenue and earnings than Integer. Elevance Health is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Integer $1.86B 1.67 $102.81M $4.01 22.78 Elevance Health $200.42B 0.45 $5.66B $23.51 17.69

Does the media favor ITGR or ELV?

In the previous week, Elevance Health had 16 more articles in the media than Integer. MarketBeat recorded 18 mentions for Elevance Health and 2 mentions for Integer. Elevance Health's average media sentiment score of 1.22 beat Integer's score of 0.00 indicating that Elevance Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Integer 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Elevance Health 13 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor ITGR or BAX?

In the previous week, Baxter International had 3 more articles in the media than Integer. MarketBeat recorded 5 mentions for Baxter International and 2 mentions for Integer. Baxter International's average media sentiment score of 0.46 beat Integer's score of 0.00 indicating that Baxter International is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Integer 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Baxter International 1 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has stronger earnings & valuation, ITGR or PODD?

Insulet has higher revenue and earnings than Integer. Integer is trading at a lower price-to-earnings ratio than Insulet, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Integer $1.86B 1.67 $102.81M $4.01 22.78 Insulet $2.71B 4.03 $247.10M $4.30 36.62

Is ITGR or PODD more profitable?

Insulet has a net margin of 10.44% compared to Integer's net margin of 7.64%. Insulet's return on equity of 26.87% beat Integer's return on equity. Company Net Margins Return on Equity Return on Assets Integer 7.64% 12.83% 6.51% Insulet 10.44% 26.87% 12.01%

Does the media favor ITGR or PODD?

In the previous week, Insulet had 42 more articles in the media than Integer. MarketBeat recorded 44 mentions for Insulet and 2 mentions for Integer. Insulet's average media sentiment score of 0.34 beat Integer's score of 0.00 indicating that Insulet is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Integer 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Insulet 11 Very Positive mention(s) 3 Positive mention(s) 26 Neutral mention(s) 1 Negative mention(s) 3 Very Negative mention(s) Neutral

Which has higher valuation & earnings, ITGR or GMED?

Globus Medical has higher revenue and earnings than Integer. Globus Medical is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Integer $1.86B 1.67 $102.81M $4.01 22.78 Globus Medical $3.10B 3.34 $537.87M $4.30 17.73

Is ITGR or GMED more profitable?

Globus Medical has a net margin of 18.92% compared to Integer's net margin of 7.64%. Globus Medical's return on equity of 13.46% beat Integer's return on equity. Company Net Margins Return on Equity Return on Assets Integer 7.64% 12.83% 6.51% Globus Medical 18.92% 13.46% 11.65%

Does the media prefer ITGR or GMED?

In the previous week, Globus Medical had 7 more articles in the media than Integer. MarketBeat recorded 9 mentions for Globus Medical and 2 mentions for Integer. Globus Medical's average media sentiment score of 0.65 beat Integer's score of 0.00 indicating that Globus Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Integer 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Globus Medical 4 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Integer (ITGR) Competitors

$91.35 -0.55 (-0.60%)

Closing price 03:59 PM Eastern

Extended Trading

$91.16 -0.19 (-0.21%)

As of 04:20 PM Eastern

Compare

ITGR vs. BDSX, ELV, BAX, PODD, and GMED

Should you buy Integer stock or one of its competitors? MarketBeat compares Integer with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Integer include Biodesix (BDSX), Elevance Health (ELV), Baxter International (BAX), Insulet (PODD), and Globus Medical (GMED). These companies are all part of the "medical" sector.

How does Integer compare to Biodesix?

Biodesix (NASDAQ:BDSX) and Integer (NYSE:ITGR) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, earnings, analyst recommendations, valuation, institutional ownership, dividends, risk and media sentiment.

Biodesix has a beta of 0.53, suggesting that its share price is 47% less volatile than the broader market. Comparatively, Integer has a beta of 0.64, suggesting that its share price is 36% less volatile than the broader market.

In the previous week, Integer had 2 more articles in the media than Biodesix. MarketBeat recorded 2 mentions for Integer and 0 mentions for Biodesix. Biodesix's average media sentiment score of 0.00 equaled Integer'saverage media sentiment score.

Company	Overall Sentiment
Biodesix	Neutral
Integer	Neutral

Integer has a net margin of 7.64% compared to Biodesix's net margin of -33.26%. Integer's return on equity of 12.83% beat Biodesix's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Biodesix	-33.26%	-2,101.40%	-35.65%
Integer	7.64%	12.83%	6.51%

21.0% of Biodesix shares are owned by institutional investors. Comparatively, 99.3% of Integer shares are owned by institutional investors. 23.2% of Biodesix shares are owned by insiders. Comparatively, 1.1% of Integer shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Integer has higher revenue and earnings than Biodesix. Biodesix is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Biodesix	$88.50M	2.36	-$35.26M	-$4.06	N/A
Integer	$1.86B	1.67	$102.81M	$4.01	22.78

Biodesix currently has a consensus price target of $28.33, indicating a potential upside of 40.61%. Integer has a consensus price target of $99.29, indicating a potential upside of 8.69%. Given Biodesix's stronger consensus rating and higher possible upside, analysts clearly believe Biodesix is more favorable than Integer.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Biodesix	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.80
Integer	1 Sell rating(s)	6 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.27

Summary

Integer beats Biodesix on 11 of the 16 factors compared between the two stocks.

How does Integer compare to Elevance Health?

Integer (NYSE:ITGR) and Elevance Health (NYSE:ELV) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, risk, earnings, media sentiment, profitability, valuation and dividends.

In the previous week, Elevance Health had 16 more articles in the media than Integer. MarketBeat recorded 18 mentions for Elevance Health and 2 mentions for Integer. Elevance Health's average media sentiment score of 1.22 beat Integer's score of 0.00 indicating that Elevance Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Integer	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Elevance Health	13 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Integer currently has a consensus target price of $99.29, suggesting a potential upside of 8.69%. Elevance Health has a consensus target price of $422.10, suggesting a potential upside of 1.47%. Given Integer's higher possible upside, analysts clearly believe Integer is more favorable than Elevance Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Integer	1 Sell rating(s)	6 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.27
Elevance Health	0 Sell rating(s)	9 Hold rating(s)	15 Buy rating(s)	0 Strong Buy rating(s)	2.63

Integer has a beta of 0.64, suggesting that its share price is 36% less volatile than the broader market. Comparatively, Elevance Health has a beta of 0.67, suggesting that its share price is 33% less volatile than the broader market.

99.3% of Integer shares are owned by institutional investors. Comparatively, 89.2% of Elevance Health shares are owned by institutional investors. 1.1% of Integer shares are owned by company insiders. Comparatively, 0.3% of Elevance Health shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Elevance Health has higher revenue and earnings than Integer. Elevance Health is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Integer	$1.86B	1.67	$102.81M	$4.01	22.78
Elevance Health	$200.42B	0.45	$5.66B	$23.51	17.69

Integer has a net margin of 7.64% compared to Elevance Health's net margin of 2.62%. Elevance Health's return on equity of 15.58% beat Integer's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Integer	7.64%	12.83%	6.51%
Elevance Health	2.62%	15.58%	5.57%

Summary

Elevance Health beats Integer on 9 of the 16 factors compared between the two stocks.

How does Integer compare to Baxter International?

Integer (NYSE:ITGR) and Baxter International (NYSE:BAX) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, earnings, risk, dividends, media sentiment, profitability, institutional ownership and valuation.

Integer has higher earnings, but lower revenue than Baxter International. Baxter International is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Integer	$1.86B	1.67	$102.81M	$4.01	22.78
Baxter International	$11.24B	1.01	-$957M	-$2.13	N/A

Integer has a net margin of 7.64% compared to Baxter International's net margin of -9.70%. Baxter International's return on equity of 16.15% beat Integer's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Integer	7.64%	12.83%	6.51%
Baxter International	-9.70%	16.15%	5.24%

99.3% of Integer shares are owned by institutional investors. Comparatively, 90.2% of Baxter International shares are owned by institutional investors. 1.1% of Integer shares are owned by insiders. Comparatively, 0.2% of Baxter International shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Integer has a beta of 0.64, indicating that its share price is 36% less volatile than the broader market. Comparatively, Baxter International has a beta of 0.62, indicating that its share price is 38% less volatile than the broader market.

Integer presently has a consensus price target of $99.29, indicating a potential upside of 8.69%. Baxter International has a consensus price target of $19.73, indicating a potential downside of 10.26%. Given Integer's stronger consensus rating and higher possible upside, analysts clearly believe Integer is more favorable than Baxter International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Integer	1 Sell rating(s)	6 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.27
Baxter International	3 Sell rating(s)	8 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	1.92

In the previous week, Baxter International had 3 more articles in the media than Integer. MarketBeat recorded 5 mentions for Baxter International and 2 mentions for Integer. Baxter International's average media sentiment score of 0.46 beat Integer's score of 0.00 indicating that Baxter International is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Integer	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Baxter International	1 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Integer beats Baxter International on 12 of the 16 factors compared between the two stocks.

How does Integer compare to Insulet?

Integer (NYSE:ITGR) and Insulet (NASDAQ:PODD) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, media sentiment, dividends, profitability, institutional ownership, analyst recommendations, risk and valuation.

Insulet has a net margin of 10.44% compared to Integer's net margin of 7.64%. Insulet's return on equity of 26.87% beat Integer's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Integer	7.64%	12.83%	6.51%
Insulet	10.44%	26.87%	12.01%

Integer has a beta of 0.64, meaning that its stock price is 36% less volatile than the broader market. Comparatively, Insulet has a beta of 1.11, meaning that its stock price is 11% more volatile than the broader market.

Insulet has higher revenue and earnings than Integer. Integer is trading at a lower price-to-earnings ratio than Insulet, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Integer	$1.86B	1.67	$102.81M	$4.01	22.78
Insulet	$2.71B	4.03	$247.10M	$4.30	36.62

99.3% of Integer shares are held by institutional investors. 1.1% of Integer shares are held by company insiders. Comparatively, 0.4% of Insulet shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Integer currently has a consensus target price of $99.29, suggesting a potential upside of 8.69%. Insulet has a consensus target price of $238.13, suggesting a potential upside of 51.23%. Given Insulet's stronger consensus rating and higher possible upside, analysts clearly believe Insulet is more favorable than Integer.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Integer	1 Sell rating(s)	6 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.27
Insulet	2 Sell rating(s)	4 Hold rating(s)	22 Buy rating(s)	0 Strong Buy rating(s)	2.71

In the previous week, Insulet had 42 more articles in the media than Integer. MarketBeat recorded 44 mentions for Insulet and 2 mentions for Integer. Insulet's average media sentiment score of 0.34 beat Integer's score of 0.00 indicating that Insulet is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Integer	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Insulet	11 Very Positive mention(s)	3 Positive mention(s)	26 Neutral mention(s)	1 Negative mention(s)	3 Very Negative mention(s)	Neutral

Summary

Insulet beats Integer on 14 of the 16 factors compared between the two stocks.

How does Integer compare to Globus Medical?

Integer (NYSE:ITGR) and Globus Medical (NYSE:GMED) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, dividends, valuation, earnings, analyst recommendations, media sentiment, risk and institutional ownership.

Integer presently has a consensus price target of $99.29, indicating a potential upside of 8.69%. Globus Medical has a consensus price target of $106.45, indicating a potential upside of 39.65%. Given Globus Medical's stronger consensus rating and higher probable upside, analysts plainly believe Globus Medical is more favorable than Integer.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Integer	1 Sell rating(s)	6 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.27
Globus Medical	0 Sell rating(s)	5 Hold rating(s)	9 Buy rating(s)	1 Strong Buy rating(s)	2.73

In the previous week, Globus Medical had 7 more articles in the media than Integer. MarketBeat recorded 9 mentions for Globus Medical and 2 mentions for Integer. Globus Medical's average media sentiment score of 0.65 beat Integer's score of 0.00 indicating that Globus Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Integer	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Globus Medical	4 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

99.3% of Integer shares are owned by institutional investors. Comparatively, 95.2% of Globus Medical shares are owned by institutional investors. 1.1% of Integer shares are owned by insiders. Comparatively, 18.4% of Globus Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Integer has a beta of 0.64, meaning that its stock price is 36% less volatile than the broader market. Comparatively, Globus Medical has a beta of 0.95, meaning that its stock price is 5% less volatile than the broader market.

Globus Medical has higher revenue and earnings than Integer. Globus Medical is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Integer	$1.86B	1.67	$102.81M	$4.01	22.78
Globus Medical	$3.10B	3.34	$537.87M	$4.30	17.73

Globus Medical has a net margin of 18.92% compared to Integer's net margin of 7.64%. Globus Medical's return on equity of 13.46% beat Integer's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Integer	7.64%	12.83%	6.51%
Globus Medical	18.92%	13.46%	11.65%

Summary

Globus Medical beats Integer on 15 of the 17 factors compared between the two stocks.

Get Integer News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ITGR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ITGR vs. The Competition

Export

Metric	Integer	MED INSTRUMENTS Industry	Medical Sector	NYSE Exchange
Market Cap	$3.10B	$7.42B	$6.91B	$23.33B
Dividend Yield	N/A	1.30%	2.67%	4.01%
P/E Ratio	22.78	51.33	27.20	30.78
Price / Sales	1.67	48.03	591.36	20.82
Price / Cash	9.01	27.04	49.34	25.43
Price / Book	1.83	7.37	10.86	4.74
Net Income	$102.81M	$159.19M	$3.56B	$1.07B
7 Day Performance	-3.69%	-0.47%	0.84%	-0.70%
1 Month Performance	-0.48%	-1.33%	5.64%	1.64%
1 Year Performance	-22.66%	1.18%	32.63%	16.02%

Integer Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ITGR Integer	1.7669 of 5 stars	$91.35 -0.6%	$99.29 +8.7%	-21.6%	$3.10B	$1.86B	22.78	11,000	News Coverage Analyst Forecast
BDSX Biodesix	3.2118 of 5 stars	$21.85 -0.6%	$28.33 +29.7%	+268.7%	$227.72M	$88.50M	N/A	220
ELV Elevance Health	4.6123 of 5 stars	$408.35 -2.3%	$420.70 +3.0%	+20.7%	$90.75B	$199.13B	17.37	97,100	Positive News Upcoming Earnings Analyst Forecast
BAX Baxter International	1.2901 of 5 stars	$22.57 -0.4%	$19.73 -12.6%	-23.0%	$11.70B	$11.24B	N/A	37,500	News Coverage
PODD Insulet	4.5151 of 5 stars	$159.77 -2.9%	$237.83 +48.9%	-46.3%	$11.39B	$2.71B	37.16	5,400	Trending News Analyst Forecast

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:ITGR) was last updated on 7/8/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Integer (ITGR) Competitors

ITGR vs. BDSX, ELV, BAX, PODD, and GMED

How does Integer compare to Biodesix?

Summary

How does Integer compare to Elevance Health?

Summary

How does Integer compare to Baxter International?

Summary

How does Integer compare to Insulet?

Summary

How does Integer compare to Globus Medical?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ITGR vs. The Competition

Integer Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Integer (ITGR) Competitors

ITGR vs. BDSX, ELV, BAX, PODD, and GMED

How does Integer compare to Biodesix?

Which has more risk and volatility, BDSX or ITGR?

Does the media prefer BDSX or ITGR?

Is BDSX or ITGR more profitable?

Do institutionals & insiders believe in BDSX or ITGR?

Which has higher earnings & valuation, BDSX or ITGR?

Do analysts recommend BDSX or ITGR?

Summary

How does Integer compare to Elevance Health?

Does the media favor ITGR or ELV?

Do analysts prefer ITGR or ELV?

Which has more volatility & risk, ITGR or ELV?

Do insiders and institutionals hold more shares of ITGR or ELV?

Which has preferable earnings & valuation, ITGR or ELV?

Is ITGR or ELV more profitable?

Summary

How does Integer compare to Baxter International?

Which has stronger earnings & valuation, ITGR or BAX?

Is ITGR or BAX more profitable?

Do insiders and institutionals hold more shares of ITGR or BAX?

Which has more risk & volatility, ITGR or BAX?

Do analysts prefer ITGR or BAX?

Does the media favor ITGR or BAX?

Summary

How does Integer compare to Insulet?

Is ITGR or PODD more profitable?

Which has more volatility & risk, ITGR or PODD?

Which has stronger earnings & valuation, ITGR or PODD?

Do institutionals and insiders have more ownership in ITGR or PODD?

Do analysts prefer ITGR or PODD?

Does the media favor ITGR or PODD?

Summary

How does Integer compare to Globus Medical?

Do analysts recommend ITGR or GMED?

Does the media prefer ITGR or GMED?

Do insiders and institutionals believe in ITGR or GMED?

Which has more volatility and risk, ITGR or GMED?

Which has higher valuation & earnings, ITGR or GMED?

Is ITGR or GMED more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ITGR vs. The Competition

Integer Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools